Treatment for Progressive Supranuclear Palsy Gets Orphan Drug Designation
According to a story from kait8.com, the drug development company Asceneuron SA recently announced that its experimental molecule ASN120290 was recently granted Orphan Drug Designation by the FDA. ASN120290 is…